Search Results for Clinical Trials
Your search produced 26 clinical trials for breast.View the clinical trial details for a full description of the study.
|
A Trial Comparing Anastrozole and Tamoxifen in Postmenopausal Patients with Breast Cancer (Ductal Cancer in Situ) who are undergoing Lumpectomy and Radiation Therapy (NSABP B-35)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
Dose-Dense Adjuvant Chemotherapy plus Bevacizumab in Lymph Node Positive Breast Cancer: a Pilot Study (421-07)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Phase I/II Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer (425-07)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Randomized Trial Comparing Treatment with Pegylated Liposomal Doxorubicin or Capecitabine as Initial Chemotherapy for Metastatic Breast Cancer in Women 60 Years and Older (265-05)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Trial of Two Schedules of Perifosine in Subjects with Breast Cancer for whom No Standard Therapy Exists (256-05)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Phase III Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone Women with Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer. (NSABP B-46-I)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Phase III Study of SU011248 in Combination with Paclitaxel vs, Bevacizumab with Paclitaxel as First Line Treatment for Patients with Advanced Breast Cancer (475-07)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Clinical Trial Comparing 16-18 Weeks of daily Exemestane, Letrozole, or Anastrozole in Postmenopausal Women with Stage II and III Estrogen Receptor Positive Breast Cancer (ACOSOG Z1031)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Double-Blind Study of Sorafenib compared to Placebo when given with Chemotherapy for Subjects with Locally Advanced or Metastatic Breast Cancer that has Progressed during or after Bevacizumab Therapy (471-07)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Phase III Study of Neoadjuvant Therapy in Patients with Operable Breast Cancer, Attempting to Identify Predictors of the Likelihood of a Clinical Response to each Regimen (NSABP B-40)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer. (NSABP P-2)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Randomized Trial of Neoadjuvant Therapy for Patients with Palpable and Operable HER2-Positive Breast Cancer, with Correlative Studies to Identify Predictors of Pathologic Complete Response. (NSABP B-41)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
Phase III Trial to Investigate the Effect and Safety of Neratinib in Patients With Overexpressed/Amplified Breast Cancer. (720-10)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Multicenter, Phase III, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination with Chemotherapy Regimens in Subjects with Previously Untreated Metastatic Breast Cancer (317-05)
Currently enrolling additional patients: No Clinical Trial Details |
|
An Open-label Study of IV RPR109881 in patients with Metastatic Breast Cancer, after Treatment with standard Therapies (anthracyclines, taxanes and capecitabine) (217-04)
Currently enrolling additional patients: No Clinical Trial Details |
|
High Dose Chemotherapy for Young Women with High Risk Breast Cancer. (063-97)
Currently enrolling additional patients: No Clinical Trial Details |
|
McGhan Medical Style 410 Silicone-Filled Breast Implant Clinical Study. (057-01)
Currently enrolling additional patients: No Clinical Trial Details |
|
GeneSearch Breast Lymph Node Assay for Intraoperative Molecular Testing (223-04s)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Retrospective review of Bevacizumab (Avastin) and Albumin Bound Paclitaxel (Abraxane) Treatment in Metastatic Breast Cancer (392-06CR)
Currently enrolling additional patients: No Clinical Trial Details |
|
Fertility Drugs and Ovarian, Endometrial, and Breast Cancer: A Multi-Institutional Study (044-95)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Randomized Study Comparing rhe Combination of Pazonib AND Lapatinib vs. Lapatinib ALONE is Patients with certain types of Inflammatory Breast Cancer (469-07)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Trial Comparing Docetaxel in Combination with Doxorubicin and Cyclophosphamide (TAC) vs. Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC-T) as Adjuvant Treatment of Operable Breast Cancer Patients with Positive Axillary Lymph Nodes. (BCIRG 005)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Trial in Post-menopausal Women with Hormone Receptor Positive Breats Cancer to Determine the Effectiveness of Letrozole compared to Placebo when given for 5 years to Subjects who have Completed 5 years of Therapy with Tamoxifen followed by an Aromatase (NSABP B-42)
Currently enrolling additional patients: No Clinical Trial Details |
|
Phase III Comparison of Adjuvant Chemotherapy With or Without Endocrine Therapy in High-Risk, Node-Negative Breast Cancer Patients, and a Natural History Follow-up Study in Low-Risk, Node-Negative Patients (SWOG 8897)
Currently enrolling additional patients: No Clinical Trial Details |
|
Phase III Trial of Continuous Schedule AC +G vs. Q2week Schedule AC, Followed by Paclitaxel Given Either Every 2 Weeks or Weekly for 12 weeks as Post-Operative Adjuvant Therapy in Node-Positive or High-Risk Negative Breast Cancer. (SWOG S0221)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Study of Sunitinib Malate as a Single Agent for the Treatment of Women with Advanced Breast Cancer. (468-07)
Currently enrolling additional patients: No Clinical Trial Details |
